Do free thyroxine levels influence the relationship between maternal serum ferritin and gestational diabetes mellitus in early pregnancy?

Copyright © 2019 Elsevier B.V. All rights reserved..

PURPOSE: The objective of this study was to estimate the combined effect of serum ferritin (SF) concentration and free thyroxine (fT4) levels on the risk of gestational diabetes mellitus (GDM).

METHODS: Women presented for antenatal care at a tertiary hospital in Shanghai, China were included in this study from December 2012 to March 2014. Women were divided into six groups according to the SF and fT4 level. Multiple logistical regression model was used to estimate odds ratio (OR) among different groups. Relative excess risk of interaction (RERI), the attributable proportion (AP) of the interaction and the synergy index (SI) were applied to evaluate the additive interaction of SF concentration and fT4 level.

RESULTS: A total of 6542 qualifying pregnant women were included in this study. We observed that a high SF concentration in early pregnancy was related to an increased risk of GDM (OR = 1.21, 95%CI: 1.02-1.43); while a low fT4 level was not (OR = 1.18, 95%CI: 0.89-1.58). There is no addictive interaction between SF and fT4 level on the presence of GDM.

CONCLUSIONS: The study suggests that only high serum ferritin concentration is associated with an increased risk of GDM in early pregnancy. The level of fT4 in early pregnancy might have no effect on the association between high SF and risk of GDM.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:151

Enthalten in:

Diabetes research and clinical practice - 151(2019) vom: 30. Mai, Seite 114-119

Sprache:

Englisch

Beteiligte Personen:

Gu, Yanqiong [VerfasserIn]
Su, Xiujuan [VerfasserIn]
Li, Yuhong [VerfasserIn]
Tang, Yuping [VerfasserIn]
Bao, Yirong [VerfasserIn]
Ying, Hao [VerfasserIn]

Links:

Volltext

Themen:

9007-73-2
Ferritins
Free thyroxine
Gestational diabetes mellitus
Isolated hypothyroxinemia
Journal Article
Q51BO43MG4
Serum ferritin
Thyroxine

Anmerkungen:

Date Completed 13.08.2019

Date Revised 13.08.2019

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.diabres.2019.03.033

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM295579226